FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...